SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) |
3 Months Ended | 4 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
May 15, 2025 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
|
| Accounting Policies [Abstract] | ||||||
| Uninsured cash balance | $ 357,500 | $ 357,500 | $ 0 | |||
| Useful life | 20 years | 20 years | ||||
| Offering costs | $ 698,570 | $ 7,626,439 | ||||
| Gross proceeds | 4,711,840 | |||||
| Debt instrument face amount | 4,330,000 | 4,330,000 | ||||
| Crowdfunding offering | 381,840 | |||||
| Deferred offering costs | 871,882 | 871,882 | ||||
| Crowdfunding offering costs | 59,468 | 90,072 | ||||
| Research and development | 293,468 | $ 452,538 | 384,731 | $ 540,939 | ||
| Marketing expense | $ 49,602 | 226,289 | $ 57,263 | 252,746 | ||
| Share price | $ 13.00 | |||||
| Share price | $ 11.68 | $ 11.68 | $ 12.71 | |||
| Income tax benefit | ||||||
| Unrecognized tax benefits | 0 | 0 | ||||
| Accrual for uncertain tax positions | $ 0 | $ 0 | ||||
| X | ||||||||||
- Definition Crowdfunding offering. No definition available.
|
| X | ||||||||||
- Definition Crowdfunding offering costs. No definition available.
|
| X | ||||||||||
- Definition Offering costs. No definition available.
|
| X | ||||||||||
- Definition Share-based compensation arrangement by share-based payment award options fair value of price per shares No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. No definition available.
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount recognized for uncertainty in income taxes classified as current. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Amount of unrecognized tax benefits. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|